MicroRNAs as master regulators of immune responses in transplant recipients

Current Opinion in Organ Transplantation

Volumn 20, Issue 1, 2015, Pages 29-36

  Kaul, Vandana ^a   Krams, Sheri ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biomarker; graft rejection; immunomodulatory; miRNAs; organ transplantation; tolerance

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

CLINICAL TRIAL (TOPIC); DENDRITIC CELL; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODY FORMATION; HUMANS; IMMUNITY, CELLULAR; MICRORNAS; ORGAN TRANSPLANTATION; TRANSPLANT RECIPIENTS;

EID: 84921414171     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000148     Document Type: Review

References (107)

1. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75:855-862.
2. Lee RC, Feinbaum RL, Ambros V, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-854.
3. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294:862-864.
4. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294:858-862.
5. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294:853-858.
6. Bronevetsky Y, Ansel KM. Regulation of miRNA biogenesis and turnover in the immune system. Immunol Rev 2013; 253:304-316.
7. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10:126-139.
8. Marson A, Levine SS, Cole MF, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008; 134:521-533.
9. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-419.
10. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
12. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123:631-640.
13. Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 2009; 10:141-148.
14. Mah S, Buske C, Humphries R, Kuchenbauer F. miRNA-: a passenger stranded in RNA-induced silencing complex? Crit Rev Eukaryot Gene Expr 2010; 20:141-148.
15. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007; 17:118-126.
16. Karreth FA, Tay Y, Perna D, et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011; 147:382-395.
17. Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long noncoding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011; 30:4750-4756.
18. Hansen TB, Wiklund ED, Bramsen JB, et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J 2011; 30:4414-4422.
19. Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012; 13:358-369.
20. Grobhans H, Filipowicz W. Molecular biology: the expanding world of small RNAs. Nature 2008; 451:414-416.
21. Erson A, Petty E. MicroRNAs in development and disease. Clin Genet 2008; 74:296-306.
22. Lodish HF, Zhou B, Liu G, Chen C-Z. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8:120-130.
23. Chang S, Wen S, Chen D, Jin P. Small regulatory RNAs in neurodevelopmental disorders. Hum Mol Genet 2009; 18 (R1):R18-R26.
24. Chen J-F, Callis TE, Wang D-Z. microRNAs and muscle disorders. J Cell Sci 2009; 122:13-20.
25. da Costa Martins P, Leptidis S, Salic K, De Windt L. MicroRNA regulation in cardiovascular disease. Curr Drug Targets 2010; 11:900-906.
26. Peter M. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 2010; 29:2161-2164.
27. Koralov SB, Muljo SA, Galler GR, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132:860-874.
28. Xu S, Guo K, Zeng Q, et al. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 2012; 119:767-776.
29. Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9:405-414.
30. Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131:146-159.
31. Rao DS, O'Connell RM, Chaudhuri AA, et al. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010; 33:48-59.
32. Spierings DC, McGoldrick D, Hamilton-Easton AM, et al. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood 2011; 117:5340-5349.
33. Boldin MP, Taganov KD, Rao DS, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208:1189-1201.
34. Knoll M, Simmons S, Bouquet C, et al. miR-221 redirects precursor B cells to the BM and regulates their residence. Eur J Immunol 2013; 43:2497-2506.
35. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316:608-611.
36. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316:604-608.
37. Vigorito E, Perks KL, Abreu-Goodger C, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27:847-859.
38. Teng G, Hakimpour P, Landgraf P, et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008; 28:621-629.
39. Dorsett Y, McBride KM, Jankovic M, et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008; 28:630-638.
40. de Yebenes VG, Belver L, Pisano DG, et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 2008; 205:2199-2206.
41. Mok Y, Schwierzeck V, Thomas DC, et al. MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production. J Immunol 2013; 191:3037-3048.
42. Wu H, Neilson JR, Kumar P, et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2007; 2:e1020.
43. Muljo SA, Ansel KM, Kanellopoulou C, et al. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202:261-269.
44. O'Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33:607-619.
45. Du C, Liu C, Kang J, et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009; 10:1252-1259.
46. Ding S, Liang Y, Zhao M, et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 2012; 64:2953-2963.
47. Takahashi H, Kanno T, Nakayamada S, et al. TGF-[beta] and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nat Immunol 2012; 13:587-595.
48. Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009; 31:457-468.
49. Baumjohann D, Kageyama R, Clingan JM, et al. The microRNA cluster miR-17-92 promotes TFH cell differentiation and represses subset-inappropriate gene expression. Nat Immunol 2013; 14:840-848.
50. Kang SG, Liu W-H, Lu P, et al. MicroRNAs of the miR-17-92 family are critical regulators of TFH differentiation. Nat Immunol 2013; 14:849-857.
51. Li Q-J, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129:147-161.
52. Chandran PA, Keller A, Weinmann L, et al. The TGF-b-inducible miR-23a cluster attenuates IFN-g levels and antigen-specific cytotoxicity in human CD8+ T cells. J Leukoc Biol 2014; 96:633-645.
53. Liston A, Lu L-F, O'Carroll D, et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008; 205: 1993-2004.
54. Zhou X, Jeker LT, Fife BT, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008; 205:1983-1991.
55. Lu L-F, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142:914-929.
56. Lu L-F, Thai T-H, Calado DP, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009; 30:80-91.
57. Okoye IS, Coomes SM, Pelly VS, et al. MicroRNA-containing T-regulatorycell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 2014; 41:89-103.
58. Fontana L, Pelosi E, Greco P, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007; 9:775-787.
59. Lu C, Huang X, Zhang X, et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011; 117:4293-4303.
60. Tserel L, Runnel T, Kisand K, et al. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 2011; 286:26487-26495.
61. Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009; 182:4994-5002.
62. Hou J, Wang P, Lin L, et al. MicroRNA-146a feedback inhibits RIG-Idependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009; 183:2150-2158.
63. Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci 2006; 103: 12481-12486.
64. O'Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci 2007; 104:1604-1609.
65. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11:141-147.
66. Androulidaki A, Iliopoulos D, Arranz A, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009; 31:220-231.
67. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci 2009; 106:7113-7118.
68. Martinez-Nunez RT, Louafi F, Friedmann PS, Sanchez-Elsner T. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by downregulation of DC-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN). J Biol Chem 2009; 284:16334-16342.
69. Krams SM, Wang M, Castillo RO, et al. Toll-like receptor 4 contributes to small intestine allograft rejection. Transplantation 2010; 90:1272.
70. Fedeli M, Napolitano A, Wong MPM, et al. Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 2009; 183:2506-2512.
71. Zheng Q, Zhou L, Mi Q-S. MicroRNA miR-150 is involved in Va14 invariant NKT cell development and function. J Immunol 2012; 188:2118-2126.
72. Bezman NA, Chakraborty T, Bender T, Lanier LL. miR-150 regulates the development of NK and iNKT cells. J Exp Med 2011; 208:2717-2731.
73. Henao-Mejia J, Williams A, Goff LA, et al. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 2013; 38:984-997.
74. Zhou L, Li K, Zheng Q, et al. microRNA miR-155 regulates NKT cell development and function by targeting ITK. J Immunol 2012; 188:; 115.6.
75. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation 2010; 90:105-112.
76. Sarma NJ, Tiriveedhi V, Ramachandran S, et al. Modulation of immune responses following solid organ transplantation by microRNA. Exp Mol Pathol 2012; 93:378-385.
77. Wen Z, Zheng S, Zhou C, et al. Bone marrow mesenchymal stem cells for postmyocardial infarction cardiac repair: microRNAs as novel regulators. J Cell Mol Med 2012; 16:657-671.
78. Guo S, Lu J, Schlanger R, et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci 2010; 107:14229-14234.
79. Feng Z, Xia Y, Zhang M, Zheng J. MicroRNA-155 regulates T cell proliferation through targeting GSK3b in cardiac allograft rejection in a murine transplantation model. Cell Immunol 2013; 281:141-149.
80. Danger R, Pallier A, Giral M, et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012; 23:597-606.
81. Lau A, Schaffert S, Qu X, Krams S. miRNA-181a is critical for the tolerogenic properties of plasmacytoid dendritic cells (TRAN3P. 886). J Immunol 2014; 192 (1 Supplement): 202.25.
82. Chen C-Z, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83-86.
83. He Y, Huang C, Sun X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell signal 2012; 24:1923-1930.
84. Ramachandran S, Hachem R, Trulock E, et al. MicroRNA 144 involved in the modulation of TGF-b signaling and fibrosis is upregulated in lung biopsies from transplant recipients undergoing chronic rejection-bronchiolitis obliterans syndrome (BOS): 2420. Transplantation 2012; 94 (10S):951.
85. Qin W, Chung AC, Huang XR, et al. TGF-b/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011; 22:1462-1474.
86. Zhong X, Chung AC, Chen H-Y, et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011; 22:1668-1681.
87. Putta S, Lanting L, Sun G, et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 2012; 23:458-469.
88. Harris A, Hatton O, Krams S, Martinez O. Modulation of the B cell miRNome by Epstein Barr virus. Am J Transplant 2014; 14 (S3):240.
89. Kim JH, Kim WS, Park C. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1. Leuk Lymphoma 2012; 53:1586-1591.
90. Gelley F, ZadoriG, Nemes B, et al. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis. J Gastroenterol Hepatol 2014; 29:121-127.
91. Joshi D, Salehi S, Brereton H, et al. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transplant 2013; 19:383-394.
92. Sarma NJ, Tiriveedhi V, Subramanian V, et al. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One 2012; 7:e50826.
93. Gehrau R, Mas V, Villamil F, et al. MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation. Am J Transplant 2013; 13:729-737.
94. Li J, McNicholas K, Yong T, et al. BK virus encoded microRNAs are present in blood of renal transplant recipients with BK viral nephropathy. Am J Transplant 2014; 14:1183-1190.
95. Nelson PT, Baldwin DA, Scearce LM, et al. Microarray-based, high-Throughput gene expression profiling of microRNAs. Nat Methods 2004; 1:155-161.
96. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 2008; 105:10513-10518.
97. Gupta SK, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 2010; 3:484-488.
98. Kumarswamy R, Thum T, Anker SD. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Circ Res 2010; 106:; e8-e.
99. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659.
100. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3:e3694.
101. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-838.
102. Lorenzen J, Volkmann I, Fiedler J, et al. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant 2011; 11:2221-2227.
103. Danger R, Paul C, Giral M, et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibodymediated rejection. PLoS One 2013; 8:e60702.
104. Meiri E, Mueller WC, Rosenwald S, et al. A second-generation microRNAbased assay for diagnosing tumor tissue origin. Oncologist 2012; 17:801-812.
105. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368:1685-1694.
106. Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol 2012; 19:60-71.
107. Shukla S, Sumaria CS, Pradeepkumar P. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook. Chem Med Chem 2010; 5:328-349.